We are live on ! Find out more
NAM

Needelman Asset Management Portfolio holdings

AUM $46M
1-Year Est. Return 8.27%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
AUM
$38.8M
AUM Growth
+$1.47M
Cap. Flow
+$677K
Cap. Flow %
1.74%
Top 10 Hldgs %
37.69%
Holding
38
New
1
Increased
11
Reduced
19
Closed
1

Top Buys

Rank Stock Value
1
VYX icon
NCR Voyix
VYX
+$1.4M
2
KHC icon
Kraft Heinz
KHC
+$17.7K
3
GE icon
GE Aerospace
GE
+$10.7K
4
T icon
AT&T
T
+$10.3K
5
AAPL icon
Apple
AAPL
+$8.87K

Sector Composition

Rank Sector Weight
1 Healthcare 24.15%
2 Financials 22.74%
3 Technology 15.59%
4 Consumer Staples 12.17%
5 Industrials 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
26
Merck
MRK
$322B
$859K 2.21%
14,054
-104
-0.7% -$6.33K
T icon
27
AT&T
T
$159B
$851K 2.19%
29,863
+351
+1% +$10.3K
YUM icon
28
Yum! Brands
YUM
$41.8B
$846K 2.18%
11,470
+70
+0.6% +$4.87K
CMG icon
29
Chipotle Mexican Grill
CMG
$47.2B
$841K 2.17%
101,000
BMY icon
30
Bristol-Myers Squibb
BMY
$133B
$819K 2.11%
14,700
WFC icon
31
Wells Fargo
WFC
$261B
$763K 1.96%
13,766
-100
-0.7% -$5.36K
MDLZ icon
32
Mondelez International
MDLZ
$79.5B
$736K 1.89%
17,040
+45
+0.3% +$2.03K
ABBV icon
33
AbbVie
ABBV
$443B
$729K 1.88%
10,057
-75
-0.7% -$5.04K
VZ icon
34
Verizon
VZ
$195B
$713K 1.84%
15,974
+31
+0.2% +$1.44K
YUMC icon
35
Yum China
YUMC
$16.5B
$450K 1.16%
11,400
IBM icon
36
IBM
IBM
$211B
$269K 0.69%
1,826
TEVA icon
37
Teva Pharmaceuticals
TEVA
$40.8B
-16,210
Closed -$520K

Similar funds

Needelman Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Needelman Asset Management held 38 positions worth $38.8M, up 3.9% from $37.4M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Needelman Asset Management's Q2 2017 filing shows 1 new, 11 increased, 19 reduced and 1 closed positions. Its largest new stake was NCR Voyix: 55,216 shares worth $1.38M. The largest sale was Teva Pharmaceuticals, an estimated $520K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

  • Needelman Asset Management's largest Q2 2017 buy was NCR Voyix: 55,216 shares worth $1.38M.
  • Needelman Asset Management added most to Kraft Heinz in Q2 2017, an estimated $17.7K increase.
  • Needelman Asset Management's biggest Q2 2017 reduction was Elevance Health, cutting an estimated $67.4K.
  • Needelman Asset Management fully exited Teva Pharmaceuticals in Q2 2017, selling an estimated $520K.
  • Needelman Asset Management's ten largest holdings make up 38% of its $38.8M portfolio in Q2 2017.
  • Needelman Asset Management opened 1 new position and closed 1 in Q2 2017.
  • Needelman Asset Management's portfolio value rose 3.9% quarter-over-quarter to $38.8M.

Based on Needelman Asset Management's 13F filing for Q2 2017, filed 7 Jul 2017.